BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10863979)

  • 1. Alterations in binding activity of T cell transcription factor CD28 responsive element binding complex (CD28RC) following allogeneic bone marrow transplantation.
    Tanaka J; Mori A; Ota S; Yamamoto Y; Kobayashi S; Hashino S; Asaka M; Imamura M
    Eur J Haematol; 2000 May; 64(5):333-9. PubMed ID: 10863979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation-related complications predicted by cytokine gene expression in the mixed lymphocyte culture in allogeneic bone marrow transplants.
    Tanaka J; Imamura M; Kasai M; Sakurada K
    Leuk Lymphoma; 1995 Sep; 19(1-2):27-32. PubMed ID: 8574169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.
    Sang W; Zhou C; Cheng N; Li Z; Zeng L; Xu K
    Immunol Lett; 2011 May; 136(2):194-202. PubMed ID: 21277900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.
    Tanaka J; Imamura M; Kasai M; Zhu X; Kobayashi S; Imai K; Hashino S; Higa T; Sakurada K; Miyazaki T
    Bone Marrow Transplant; 1994 Nov; 14(5):695-701. PubMed ID: 7889002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling-based identification of CD28 and PI3K as new biomarkers for chronic graft-versus-host disease.
    Lai P; Weng J; Lu Z; Guo R; Luo C; Wu S; Ling W; Geng S; Du X
    DNA Cell Biol; 2011 Dec; 30(12):1019-25. PubMed ID: 21682596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells.
    Tanaka J; Mielcarek M; Torok-Storb B
    Blood; 1998 Jan; 91(1):347-52. PubMed ID: 9414304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis.
    Ohata J; Sakurai J; Saito K; Tani K; Asano S; Azuma M
    Clin Exp Immunol; 2002 Jul; 129(1):61-8. PubMed ID: 12100023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
    Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical separation of cGvHD and GvL and better GvHD-free/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML.
    Zheng CC; Zhu XY; Tang BL; Zhang XH; Zhang L; Geng LQ; Liu HL; Sun ZM
    Bone Marrow Transplant; 2017 Jan; 52(1):88-94. PubMed ID: 27376453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HLA-C-specific natural killer cell receptors (CD158a and CD158b) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation.
    Tanaka J; Mori A; Ohta S; Yamamoto Y; Kobayashi S; Hashino S; Kobayashi M; Asaka M; Imamura M
    Br J Haematol; 2000 Mar; 108(4):778-83. PubMed ID: 10792283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine receptor gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation.
    Tanaka J; Imamura M; Kasai M; Zhu X; Kobayashi S; Hashino S; Higa T; Sakurada K; Asaka M
    Leuk Lymphoma; 1995 Oct; 19(3-4):281-7. PubMed ID: 8535220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
    Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host disease.
    Carayol G; Bourhis JH; Guillard M; Bosq J; Pailler C; Castagna L; Vernant JP; Pico JL; Hayat M; Chouaib S; Caignard A
    Transplantation; 1997 May; 63(9):1307-13. PubMed ID: 9158026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells.
    Blazar BR; Taylor PA; Boyer MW; Panoskaltsis-Mortari A; Allison JP; Vallera DA
    J Immunol; 1997 Oct; 159(7):3460-73. PubMed ID: 9317145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model.
    Marcondes AM; Li X; Tabellini L; Bartenstein M; Kabacka J; Sale GE; Hansen JA; Dinarello CA; Deeg HJ
    Blood; 2011 Nov; 118(18):5031-9. PubMed ID: 21900190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased proportion of HLA-class-I-specific natural killer cell receptors (CD94) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation.
    Tanaka J; Tutumi Y; Zhang L; Mori A; Kahata K; Toyoshima N; Ohta S; Kobayashi S; Hashino S; Asaka M; Imamura M
    Acta Haematol; 2001; 105(2):89-91. PubMed ID: 11408710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloanergization Method for Inducing Allospecific Hyporesponsiveness in PBMC Exposed to Allostimulation In Vitro in the Context of Costimulatory Molecule Blockade.
    Barbon CM; Janec KJ; Kelner RH; Norton JE; Guinan EC
    Methods Mol Biol; 2019; 1899():103-118. PubMed ID: 30649768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
    van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
    Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.